CD4+ CD25high FOXP3+ Regulatory T Cells Correlate with FEV1 in North Indian Children with Cystic Fibrosis

被引:16
作者
Anil, Nidhi [1 ]
Singh, Meenu [1 ]
机构
[1] Postgrad Inst Med Educ & Res PGIMER, Dept Pediat, Chandigarh 160012, India
关键词
Cystic fibrosis; FEV1; regulatory T cells; EXPRESSION;
D O I
10.3109/08820139.2014.888447
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cystic fibrosis (CF) lung disease is characterized by dysregulated inflammatory response in the airways. CD4(+)CD25(+) regulatory T cells play a crucial role in maintaining the immune homeostasis. However their role in the disease pathogenesis of CF remains unexplored. Aim: To determine the percentage of circulating CD4(+)CD25(high), FoxP3(+) T cell expression in children with CF and controls. Furthermore to evaluate the relationship between CD4(+)CD25(high), FOXP3 T cell % and the clinical status of the disease (lung function). Methods: CD4(+)CD25(+), intracellular FoxP3 expression in peripheral blood were estimated using flowcytometry in 20 children with CF and 10 healthy controls. Spirometry was carried out according to the standard guidelines. Results: We observed a significant difference in CD4(+)CD25(+)T cell% in children with CF (5.2 +/- 1.2) versus controls (6.8 +/- 1.4, p<0.05), CD4(+)CD25(high)Tcell% in CF (1.72 +/- 0.36) versus controls (2.59 + 0.42, p<0.003). Similarly a significant difference was observed in FoxP3 T cell% CF: (60.7 +/- 6.19) versus controls (76.8 +/- 5.16), p<0.001. A significant positive correlation between FoxP3 T cell% and FEV1 in children with CF(r = 0.822, p<0.01) was observed. CD4(+)CD25(high) T cell% correlated positively with FEV1 (r = 0.742, p<0.01). Conclusion: Our findings report the first evidence of a decreased expression of circulating CD4(+)CD25(high) FoxP3(+) T cells in children with CF. Furthermore circulating CD4+ CD25(high), FOXP3(+) T cell percentage correlated with FEV1.
引用
收藏
页码:535 / 543
页数:9
相关论文
共 25 条
  • [1] Role of regulatory T cells in allergy and asthma
    Akbari, O
    Stock, P
    DeKruyff, RH
    Umetsu, DT
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (06) : 627 - 633
  • [2] Human CD4+CD25+ regulatory T cells
    Baecher-Allan, C
    Viglietta, V
    Hafler, DA
    [J]. SEMINARS IN IMMUNOLOGY, 2004, 16 (02) : 89 - 97
  • [3] Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production
    Bellinghausen, I
    Klostermann, B
    Knop, J
    Saloga, J
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (04) : 862 - 868
  • [4] Natural versus adaptive regulatory T cells
    Bluestone, JA
    Abbas, AK
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) : 253 - 257
  • [5] New concepts of the pathogenesis of cystic fibrosis lung disease
    Boucher, RC
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (01) : 146 - 158
  • [6] State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?
    Chmiel, JF
    Davis, PB
    [J]. RESPIRATORY RESEARCH, 2003, 4 (08)
  • [7] Cystic fibrosis
    Davis, PB
    Drumm, M
    Konstan, MW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) : 1229 - 1256
  • [8] Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
    Decraene, Ann
    Willems-Widyastuti, Anna
    Kasran, Ahmad
    De Boeck, Kris
    Bullens, Dominique M.
    Dupont, Lieven J.
    [J]. RESPIRATORY RESEARCH, 2010, 11
  • [9] Airway inflammation in cystic fibrosis
    Elizur, Arnon
    Cannon, Carolyn L.
    Ferkol, Thomas W.
    [J]. CHEST, 2008, 133 (02) : 489 - 495
  • [10] Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma
    Hartl, Dominik
    Koller, Barbara
    Mehlhorn, Alexander T.
    Reinhardt, Dietrich
    Nicolai, Thomas
    Schendel, Dolores J.
    Griese, Matthias
    Krauss-Etschmann, Susanne
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (05) : 1258 - 1266